Category archives: Cancer drugs

Men with testicular cancer: Their Side effects, Diagnosis and Treatment

Men with testicular cancer: Their Side effects, Diagnosis and Treatment
Men with testicular cancer: Their Side effects, Diagnosis and Treatment Chemotherapy for men with testicular cancer could be made 'shorter, kinder and cheaper' with a new type of therapy. Researchers testing a combination of three drugs found a single three-week cycle was just as effective as the standard six weeks...

Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high

Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high
Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high ORLANDO ? The price of generic imatinib has decreased substantially in the United States over the past 2 years, according to a speaker at ASH Annual Meeting and Exposition. The decline comes after steep increases in...

{Taj Life Sciences}: Women’s Healthcare Awareness Initiative

{Taj Life Sciences}: Women’s Healthcare Awareness Initiative
Women?s Poor health condition in India: There?s lack of awareness about women?s health in India, mostly due to the taboos and superstitions associated with female genital hygiene and menstruation. Every 8 minutes, an Indian woman dies due to cervical cancer. Statistics state that this is the second-most common cancer among...

Look back at the decade: Generic drugs

Look back at the decade: Generic drugs
Fifteen years after it rose and went limp, the biotech sector saw a bull run of sorts In 2010, an unusual protest erupted over a still negotiated and secret free trade agreement between India and the European Union. Protesters were people living with HIV/AIDS and cancer. They saw a threat...

WHO signs MOU with International Generic and Biosimilar Medicines Association to promote access

WHO signs MOU with International Generic and Biosimilar Medicines Association to promote access
WHO signs MOU with International Generic and Biosimilar Medicines Association to promote access Full access to medicines is hampered by a variety of factors. Two important barriers are high prices and regulatory issues such as long lag times in bringing medicines to market. To address these issues, Dr Tedros Adhanom...